ClinicalTrials.gov
ClinicalTrials.gov Menu

Maximum Targeted Ablation of Atrial Flutter

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00491010
Recruitment Status : Unknown
Verified June 2007 by Lawson Health Research Institute.
Recruitment status was:  Recruiting
First Posted : June 25, 2007
Last Update Posted : June 25, 2007
Sponsor:
Information provided by:
Lawson Health Research Institute

Brief Summary:
Patients undergoing atrial flutter ablation will be randomized to either the standard ablation approach or voltage targeted approach. Patients will be followed for one year to assess outcome of the ablation technique

Condition or disease Intervention/treatment Phase
Atrial Flutter Procedure: radiofrequency catheter ablation Phase 4

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Maximum Targeted Ablation of Atrial Flutter
Study Start Date : July 2006
Estimated Study Completion Date : February 2008




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients undergoing TV-IVC isthmus ablatin for atrial flutter

Exclusion Criteria:

  • atypical atrial flutter
  • <18 years old any atrial surgery or pacemaker refusal to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00491010


Contacts
Contact: Allan Skanes, MD 519-685-8500 ext 32739 askanes@uwo.ca
Contact: Lorne gula, MD 519 685-8500 ext 32739 lgula@uwo.ca

Locations
Canada, Ontario
London Health Sciences Center Recruiting
London, Ontario, Canada, N6A 5A5
Sub-Investigator: Lorne Gula, MD         
Sponsors and Collaborators
Lawson Health Research Institute
Investigators
Principal Investigator: Allan c Skanes, MD University of Western Ontario, London Health Sciences Center

ClinicalTrials.gov Identifier: NCT00491010     History of Changes
Other Study ID Numbers: R-06-153
12266
First Posted: June 25, 2007    Key Record Dates
Last Update Posted: June 25, 2007
Last Verified: June 2007

Keywords provided by Lawson Health Research Institute:
atrial flutter
ablation
voltage targeted

Additional relevant MeSH terms:
Atrial Flutter
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes